Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Current Assets (2020 - 2025)

HCW Biologics (HCWB) has disclosed Current Assets for 6 consecutive years, with $1.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Assets fell 24.15% year-over-year to $1.6 million, compared with a TTM value of $1.6 million through Sep 2025, down 24.15%, and an annual FY2024 reading of $5.7 million, down 11.02% over the prior year.
  • Current Assets was $1.6 million for Q3 2025 at HCW Biologics, down from $2.9 million in the prior quarter.
  • Across five years, Current Assets topped out at $43.6 million in Q3 2021 and bottomed at $1.6 million in Q3 2025.
  • Average Current Assets over 5 years is $17.9 million, with a median of $11.9 million recorded in 2021.
  • The sharpest move saw Current Assets skyrocketed 244.69% in 2022, then plummeted 87.95% in 2024.
  • Year by year, Current Assets stood at $40.5 million in 2021, then decreased by 15.83% to $34.1 million in 2022, then crashed by 81.2% to $6.4 million in 2023, then fell by 11.02% to $5.7 million in 2024, then tumbled by 72.12% to $1.6 million in 2025.
  • Business Quant data shows Current Assets for HCWB at $1.6 million in Q3 2025, $2.9 million in Q2 2025, and $1.9 million in Q1 2025.